Research programme: encapsulated methionine gamma lyase - ERYtech PharmaAlternative Names: ERY-MET; erythrocyte encapsulated methionine γ lyase
Latest Information Update: 20 Jan 2017
At a glance
- Originator ERYtech Pharma
- Class Antineoplastics; Carbon sulfur lyases
- Mechanism of Action Amino-acid-modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cancer